Institutional Ownership Dyne Therapeutics, Inc. (DYN)
This table provides information about the institutional ownership of Dyne Therapeutics, Inc. (DYN). We have compiled data on the 214 institutions that hold shares in the stock, with a total of 103 Million shares, which have been reported (via 13F filing form) to have a value of $1.43 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Atlas Venture Life Science Advisors, LLC
|
Feb 06, 2025 Q4 2024 |
8,019,354
shares
|
$111 Million
31.16% of portfolio
|
Q4 2024
Reduced 0.01%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
7,386,988
shares
|
$102 Million
0.01% of portfolio
|
Q2 2024
Added 37.05%
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
7,379,309
shares
|
$102 Million
0.09% of portfolio
|
Q4 2024
Added 8.31%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
6,703,926
shares
|
$92.6 Million
0.0% of portfolio
|
Q4 2024
Reduced 2.33%
|
|
Ra Capital Management, L.P.
Boston, MA |
Feb 14, 2025 Q4 2024 |
6,381,144
shares
|
$88.2 Million
2.43% of portfolio
|
Q3 2024
Added 5.49%
|
|
Fcpm Iii Services B.V.
Naarden, P7 |
Feb 14, 2025 Q4 2024 |
5,462,846
shares
|
$75.5 Million
21.73% of portfolio
|
Q4 2024
Reduced 8.25%
|
|
Rtw Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
5,218,641
shares
|
$72.1 Million
2.01% of portfolio
|
Q4 2024
Reduced 23.47%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
3,717,383
shares
|
$51.4 Million
0.0% of portfolio
|
Q4 2024
Added 2.07%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
2,861,581
shares
|
$39.5 Million
0.01% of portfolio
|
Q4 2024
Reduced 2.65%
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Feb 14, 2025 Q4 2024 |
2,650,150
shares
|
$36.6 Million
10.2% of portfolio
|
Q1 2024
Added 60.6%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
2,402,452
shares
|
$33.2 Million
0.01% of portfolio
|
Q4 2024
Reduced 8.87%
|
|
Holocene Advisors, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,348,161
shares
|
$32.5 Million
0.19% of portfolio
|
Q4 2024
Added 18.44%
|
|
Vr Adviser, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
2,173,913
shares
|
$30 Million
8.45% of portfolio
|
Q2 2023
New holding
|
|
Deep Track Capital, LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
2,000,000
shares
|
$27.6 Million
2.08% of portfolio
|
Q4 2024
Reduced 39.06%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,950,000
shares
|
$26.9 Million
0.08% of portfolio
|
Q4 2024
Reduced 18.85%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,887,329
shares
|
$26.1 Million
0.0% of portfolio
|
Q4 2024
Added 1.5%
|
|
Jefferies Financial Group Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
1,800,000
shares
|
$24.9 Million
0.27% of portfolio
|
Q4 2024
New holding
|
|
Siren, L.L.C.
New York, NY |
Feb 14, 2025 Q4 2024 |
1,347,456
shares
|
$18.6 Million
1.4% of portfolio
|
Q4 2024
Added 18.75%
|
|
Franklin Resources Inc
San Mateo, CA |
Feb 12, 2025 Q4 2024 |
1,323,803
shares
|
$18.3 Million
0.01% of portfolio
|
Q4 2024
Reduced 1.39%
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
1,227,080
shares
|
$17 Million
0.78% of portfolio
|
Q4 2024
Added 73.22%
|
|
Jennison Associates LLC
|
Jan 24, 2025 Q4 2024 |
1,211,915
shares
|
$16.7 Million
0.02% of portfolio
|
Q4 2024
Reduced 10.03%
|
|
Vivo Capital, LLC
Palo Alto, CA |
Feb 13, 2025 Q4 2024 |
1,114,960
shares
|
$15.4 Million
5.13% of portfolio
|
Q3 2024
Reduced 31.81%
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
1,071,498
shares
|
$14.8 Million
2.06% of portfolio
|
Q4 2024
Added 38.78%
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Feb 13, 2025 Q4 2024 |
1,056,241
shares
|
$14.6 Million
0.06% of portfolio
|
Q4 2024
Reduced 13.22%
|
|
Armistice Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
964,518
shares
|
$13.3 Million
0.32% of portfolio
|
Q4 2024
Reduced 16.51%
|